Targeted therapies: Manufacturer sponsorship bias in economic analyses matters
Kerr D., Elzawawy A.
A qualitative study indicates that there is a positive selection bias towards favourable economic analysis of targeted therapies, when these are funded by the manufacturer. At a time of increasing budgetary constraints and public scrutiny of the relationship between industry and the professions, we need a more mixed economy of funding for this field. © 2012 Macmillan Publishers Limited. All rights reserved.